ArticleTranslational lung cancer research2025

MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Ayami Kaneko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.